RespireRx Pharmaceuticals Inc (CE) (RSPI) ニュース

Yeah. That PhD thesis which is no longer posted noted that he could not publish until 2026. I believe that was out of the UK. I am not sure if all universities require peer-revied publication to award a PhD, but UCSD sure did for my daughter. Implies that PhD candidate will not be awarded his PhD until 2026 and also access to CX9292 had a NDA associated. CX929 does not appear to have patent protection.

I don’t think they have any patent protection on old compounds academics may be studying..

I don't disagree. I'm boggled just as much.

It would help them alot to come out and say they have NDA's in place. That alone would would speak volume to the shareholder IMO. It is completely legal to say they are involved in NDA(s) . GLTA

That's what I have been saying for months. I believe Lippa, Cerna and associates have made their compounds available to universities around the world. The prices are truly cheap. I suspect there is an NDA agreement attached. So, as I said before, RSPI is getting first class, worldwide research on the cheap. The most innovative research comes from universities which RSPI has tapped into.

But look at all the peer-reviewed papers in 2024. That’s a hell of a lot of detailed work. Actually this is more than what some entire academic departments output.

Almost like they want to draw any and all attention away from themselves and the only asset currently engaged in much is KRM-ll-81. The OSA and ampakine platform has been well known for a long time and still looking to coordinate funding, so this illogical action in regard to filings, etc is most likely associated with the gabakine program. The selectivity may just put it in a select group of candidates worth quite a few pennies.. or nickels or dimes..

Thing is I think this approach will only draw more eyes here.

Oh what a mess and shame that would be and at that point all the effort to get these promising candidates to the point of clinicals would be lost

Nah it's all speculation till filling or proceedings are official made for revocation process to begin. Which should've happened already with them missing the date to file. So with limit info it may very well be a stretch but it's possible Jeff communicated a sufficient reasoning for them withholding filling. That could very well be the reason the SEC hasn't motion that filling.

What reason might that be? To accept revocation proceedings and be done with it forever. That's what's about to happen.

I share the same sentiment otherwise all this time idly wasting away makes no reasonable sense. Even if they were scammers like ENZC they utterly failed to replicate their results. Enzc tultized any lil micro news drop to allow price to rise and then slowly dilute to hell. Yet here they repeatedly have done a poor job to maximize profits or SP. Instead they tried to diminish sustained runs. Also low conversions were being made. Looks as if they had no interest in stock's performance by their management descions. Makes one curious what sort of behind the curtain scene is occurring.

I think their responses in regards to form 15 essentially suggests that they just don't want to do that...

They must have a reason to not want this trading right now. What might that reason be?

"Just my thoughts! It seems that there is not an asserted effort right now to become current"

That has now become clear. They have no clarity or strategy in regards to this EM situation. Why not take a bridge loan out or utilize their network of well off individuals to simply finance the SEC filings that is their duty and responsibility versus tarnish their image? They still could be negotiating multiple deals but with the benefit of financials in place for current and prospective shareholders as well as potential partners/resources.

Harken back to the CEO's words which IMO are very genuine and pure. KRM-ll-81 is "remarkable", successful in every single model... hoping to open "purse strings"... Couple with the gravity of progressing (closing in on culminating?) in the NIH IND enabling studies. Well this might just be THE premier preclinical candidate for pain and worth huge amounts of up front payments and milestones in any agreement. The NIH isn't going to want control of these studies coming out of their HEAL program subject to the whims of a barely functional OTC stock on some obscure trading platform.

All the items they talk about doing in the shareholder letter is ONLY possible if they have a transformative deal in the works. Conclusion: It's coming.

.0011 x .0020

It's a good faith estimate on how many shareholders on record. Mark it at 299 and post the Form 15 ASAP

That meets the requirement and once Form 15 effective, never hear from SEC again.

"Form 15 is not available to every company. You have to have less than a certain number of shareholders. We have too many if CEDE & Co (street name) does not count as a single shareholder and instead is representative of all street name holders. I don’t know the answer to that and have inquired of the SEC. No answer yet."

He should know this and he shouldn't have to ask the SEC.
1. The certain number of shareholders of record that would apply to RSPI is 300.
2. CEDE IS counted as a single shareholder.

Form 15 is almost certainly available to RSPI based on the above.

An interesting read , I know it is not RSPI just that things are moving for pain relief . GLTA
https://www.msn.com/en-us/health/other/compound-mimics-cannabis-for-pain-relief-without-the-side-effects-mouse-study-points-to-effective-opioid-alternative/ar-AA1Ajt09?ocid=hpmsn&cvid=9777833c564f4560c42530cedf7e6ceb&ei=35

With this incredible pipeline, how could it be anything else?

Yep, seems nonsensical explanations sometimes portend deals are being formulated, IMO.

Just my thoughts! It seems that there is not an asserted effort right now to become current. Could the reason be that a deal is in the works and takes priority over moving off Expert Market? Certainly makes me wonder.

Yeah that seems like a brilliant path/idea for garnering success and pushing these platforms into clinical trials...

Only going to create a bigger mess and then who is going to want to develop any of these candidates?

Yep with revocation knocking at their door, no NDA or any other issue would justify the situation they are facing

Not sure about that. The current direction is revocation of SEC registration... And how much would that mess take to recover from?

That does say a lot then now doesn't it. Not knowing what their options even are after all this time suggests they did not even care what the options would be when they entered EM. So it clearly is now a purposeful endeavour OR a method to the madness...

So now why? Is there an NDA in place related to KRM-ll-81 coming out of the NIH IND enabling studies? Or a major finance agreement in the works for the neuromodulator platforms/EndeavourRx? Or BOTH?

Well, so far as I understand form 15 would be a step in the other direction than toward becoming pink current again.

Well folks are welcome to email him and argue the point, for now we in limbo.

What the hell is he talking about that Form 15 and going pink current on OTCmarkets reporting standard may not be in the best interest of shareholders and "certainly precludes trading"?!? Trading would resume under pink current status on otcmarkets. This makes zero sense. 

It's unreal that in 9 months he hasn't fully researched every option available to them, specifically form 15, which some of us here even discussed as a potential option to forward to them in an email last June. What does this guy spend 5 days a week doing exactly?

That is complete bs that it's the same cost as $100,000 plus SEC audited fins for a fking securities lawyer to sign off on a yearly report for OTCmarkets. 

I've been in OTC's in the last 4 years where the CEO flat out said what the exact cost was to stay pink current via lawyer signing off on the yearly report and it was no where close to SEC audited fins...

But it DOES matter...

So after 9 months on this Expert Market, they do not even know if form 15 is an option... LMAO.. excuse excuse excuse.

Was there truth to the emoji people that they wanted to take company private?

Yeah, and lets not do things easy or less expensive for the company..

Of course I am invested. I managed to grab over 5 million just before EM. I suspect the 200,000 I lost on Cortex will be but a bad memory, but my wife is looking at me and saying, "a fool and his money are soon parted." I just don't think this delay in EM will matter, "there is method to this madness."

Thank you !

It is a most puzzling direction and course to get there for sure . GLTA

What type of time period are they thinking before it is ? Not an exact date but time range . thanks

I'm not sure their strategy if they even have 1

That is exactly what I just got back . GLTA

OK here's Jeff response on filing form 15..."Form 15 is not available to every company. You have to have less than a certain number of shareholders. We have too many if CEDE & Co (street name) does not count as a single shareholder and instead is representative of all street name holders. I don’t know the answer to that and have inquired of the SEC. No answer yet. That being said, even if we were eligible, I’m not sure that it’s in the best interests of our shareholders. It certainly precludes trading. Does not relieve us of the obligation to file past financial reports and it makes us totally dark. We’d stop reporting entirely. We would not even file 8-K’s which is one way we try to achieve transparency. We might be able to meet the OTC alternative filing requirements, but the cost of doing so, especially getting a legal letter, would be about the same as the cost of our accountants to get current. So we haven’t ruled our Form 15, but without a doubt, I want to make sure that we do what is best for all shareholders, not just find a way to make it easy or less expensive for the company."

 

Sincerely,

 

Jeff

 

"I am not certain all positioning like hedging and loaning shares here and there are reportable to finra."
I guess you didn't like my answer. You don't accept the accuracy of the Short Interest Report?
There's no evidence that there is or was a significant short position in this Company. There rarely is in a Company that has traded for less than a penny for as long as this one has....there's no money in it and plenty of risk.

Are you invested as a shareholder?

I don't see how this EM strategy is benefitting shareholders and the potential to develop premier candidates. Are all the convertible debt and other financial agreements in default costing shareholders additional money per those agreements? Does the lack of professional presentation cost opportunity to attract resources either personnel or capital? Is the lack of financial transparency, business strategy and allowing for severly undervalued equity costing time, money and flexibility to develop all assets for best ROI providing all candidates the chance to succeed down clinical paths?

"Managment is acting like it has a corner on a multi-billion dollar market"... Maybe they do with KRM-ll-81.

LT, from my standpoint, I am not bothered at all what RSPI is doing in business,. I am excited by the science and expect a very large return on my investment. IMO Managment is acting like it has a corner on a multi-billion dollar market. My understanding of the all its peer- reviewed papers that RSPI will be the company behind major neurological cures.

No idea. Just trying to understand why a company with a solid history and has listed SEC compliance as a source of pride on past presentations would suddenly STOP all that with lame excuse after excuse. The shareholder letter and activities they are pursuing is exactly the type of stuff pharma investors want to see action on in a publicly traded vehicle..

Yet ZERO clarity on their path/intent to trading and this ridiculous EM strategy after 9 months!!.. Lack of professional presentation. Seems like quite a gambit to put all this tarnish on everything.. to what end... If they didn't want to be a public company they screwed that one up years ago when they acquired these assets and continued to develop them and sell it to public retail shareholders....

Who knows. That was a lot of relative volume on the DOD news and I am not certain all positioning like hedging and loaning shares here and there are reportable to finra. But I do think people agree as to the self-inflicted part of the story...

I have to double check but I think I'm about a month behind you, the bulk sometime in April. And I bought more in June as well. I personally don't think anything an OTC exec is going to reply to a retail shareholder with is going to be useful or truthful info, plus they can't reveal insider info anyway, so I'm not going to bother emailing. 

Exactly. It's unacceptable that the Form 15 and transfer agent situation isn't already handled. Especially after 8 months on EM now and the threat of revocation from the SEC. 

Hopefully you're right. After some bad experiences on the OTC the last few years, I'm praying it's a different outcome here. 

I agree with no short interest everything self inflicted stirred along with self sabotaging 

I hear you , maybe write Jeff and vent your frustration , question about form 15 and see what he replies with. I just went back to see when my holding started here 3/7/2024 for 9m and the other 6m will be a year over the next 20 days. Yes it has been along wait without being able to see how this would have traded over the last year basically. Hopefully the wait is coming to an end , or maybe we look at our account one day and it has a # with a bunch of Zeros behind it and no shares in it . GLTA

A Form 15 is a simple one page document. A check mark and an Integer # of shareholders on record. It also costs zero dollars to file it.

Not taking the first step shows they purposely want this to get revoked.

The second red flag is not being transfer agent verified.

All this could have been taken care of in July 2024. It's a very simple process.

If you choose not to believe FINRA's Short Interest Report I can't help you.
There is no significant short interest in RSPI and if there was it would have been covered long ago, when the price fell apart.

“purposely done and continues to be purposely kept from trading”…

Who benefits from such decisions? Surely not the company, their reputation and the assets. I don’t think they want any retail shareholders as they have done the complete opposite to attract any investors..

Some speculate an NDA is cause for such action especially now in light of they talking about strategic discussions and commercial proposals and in licensing which is funny concept considering the excuses of no money, no filings..

To pull this on shareholders and tarnish impressions to potential partners and collaborators, well there must be one hell of a whale hooked on the line here! IMO.